Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3466 AL 3480

Integrating Dopamine and BDNF Hypotheses: The Role of Dopamine-BDNF Crosstalk in Neuropathologies

Alsalloum M, Tsybko A, Naumenko V.

Biochemistry (Mosc). 2026 May;91(5):637-657. doi: 10.1134/S0006297925604125.

Dysphagia Management in Individuals With Parkinson Disease and Cognitive Dysfunction: A Scoping Review

Rangwala R, Lee G, Benge JF, Jones CA.

Arch Phys Med Rehabil. 2026 Mar 22:S0003-9993(26)00620-9. doi: 10.1016/j.apmr.2026.03.012. Online ahead of print.

Wernicke's encephalopathy unmasking progressive supranuclear palsy and Alzheimer's pathology: a diagnostic challenge in an older adult

Defalque I, Ribeiro Da Costa R, Scheffler M, Mendes A.

BMJ Case Rep. 2026 Jan 6;19(1):e269430. doi: 10.1136/bcr-2025-269430.

Pearls & Oy-sters: Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia

German A, Grotemeyer A, Rothhammer V, Doerfler A, Winkler J, Regensburger M.

Neurology. 2026 Feb 10;106(3):e214622. doi: 10.1212/WNL.0000000000214622. Epub 2026 Jan 8.

In vitro-prepared A30P alpha-synuclein fibrils adopt the conserved and disease-relevant Greek key fold

Milchberg MH, Warmuth OA, Borcik CG, Han R, Harding BD, Dhavale DD, Kotzbauer PT, Wright ER, Schwieters CD, Rienstra CM.

bioRxiv [Preprint]. 2026 Feb 5:2026.02.03.703603. doi: 10.64898/2026.02.03.703603.

Normative modeling of brain function abnormalities in complex pathology requires a whole-brain approach

Kobbersmed JRL, Gohil C, Marquand A, Vidaurre D.

Prog Neurobiol. 2026 May;260:102906. doi: 10.1016/j.pneurobio.2026.102906. Epub 2026 Mar 17.

Plant natural products targeting NLRP3 inflammasome in Parkinson's disease: Molecular activation and regulation to therapeutics

Lu H, Zeng F, Sun J, Li B, Lei Z, Zeng C, Zhu C, Sheng Y, Peng Q, Sun Y, Zhang S.

iScience. 2026 Mar 6;29(4):115257. doi: 10.1016/j.isci.2026.115257. eCollection 2026 Apr 17.

Recent Developments in the Drug Treatment of Parkinson's Disease

Leiter S, Mahlknecht P, Poewe W.

Drugs. 2026 May 21. doi: 10.1007/s40265-026-02327-9. Online ahead of print.

Multifactorial anticholinergic toxicity-like presentation and malignant parkinsonism in Perry syndrome

Takezaki Y, Iriki Y, Madokoro Y, Shimono K, Sato M, Niiyama S, Kamikokuryo C, Kakihana Y.

Parkinsonism Relat Disord. 2026 May;146:108287. doi: 10.1016/j.parkreldis.2026.108287. Epub 2026 Mar 16.

Impact and management of cognition on speech and swallow function in Parkinson's disease

Savage-Black M, Sevitz JS, Rogus-Pulia NM.

J Parkinsons Dis. 2026 May 25:1877718X261444487. doi: 10.1177/1877718X261444487. Online ahead of print.

Aging and the microbiome: implications for health and disease

Gao W, Lee HY, Min KJ.

BMB Rep. 2026 Jan;59(1):40-50. doi: 10.5483/BMBRep.2025-0152.

Elovanoids: linking nutrition to neuroprotection

Bazan NG.

Curr Opin Clin Nutr Metab Care. 2026 Mar 1;29(2):111-122. doi: 10.1097/MCO.0000000000001198. Epub 2026 Jan 8.

When Proteins Go MAD-Misfolded, Amplified, Detected: Advances in α-Synuclein Pathophysiology and RT-QuIC Detection

Labajová N, Polák A, Cehlár O, Križan P, Hritz J, Kolisek M, Škorvánek M, Škrabana R, Kovačech B, Žilka N.

Mol Neurobiol. 2026 Jan 9;63(1):352. doi: 10.1007/s12035-025-05600-2.

Explore thyself: is it time for metacognition screening in clinical trials?

McGarry A, Kim SYH, Auinger P, Venuto C, Gaughan J.

Clin Park Relat Disord. 2026 Jan 9;14:100424. doi: 10.1016/j.prdoa.2026.100424. eCollection 2026.

Silent Intruders: The Gut Virome in Brain Aging and Cognitive Decline

Silvestro S, Midiri A, Biondo C, Casilli S, Borrello L, Zummo S, Mancuso G.

Pathogens. 2026 Feb 6;15(2):180. doi: 10.3390/pathogens15020180.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias